NCT05778968 is a NA clinical trial of low etco2 in End-tidal Sevoflurane, sponsored by Tanta University.

Who is sponsoring NCT05778968?

NCT05778968 is sponsored by Tanta University.

What drugs are being tested in NCT05778968?

Interventions in NCT05778968: low etco2, normal etco2, high etco2.

What condition does NCT05778968 study?

NCT05778968 studies End-tidal Sevoflurane, End-tidal Carbon Dioxide, Minimum Alveolar Concentration.

Is NCT05778968 still recruiting?

NCT05778968 is currently completed. Last updated 30 July 2024.

Last reviewed 2024-07-30 · How we verify

NCT05778968

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Etco2 Levels on the End-tidal Concentration of Sevoflurane

Completed NA Last updated 30 July 2024

What this trial tests

NA trial testing low etco2 in End-tidal Sevoflurane in 90 participants. Completed in 29 July 2024.

Timeline

1 February 2023

Primary endpoint
1 June 2024

29 July 2024

Quick facts

Lead sponsor	Tanta University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	90
Start date	1 February 2023
Primary completion	1 June 2024
Estimated completion	29 July 2024
Sites	1 location across Egypt

Drugs / interventions tested

low etco2
normal etco2
high etco2

Conditions studied

End-tidal Sevoflurane — all drugs for End-tidal Sevoflurane →
End-tidal Carbon Dioxide — all drugs for End-tidal Carbon Dioxide →
Minimum Alveolar Concentration — all drugs for Minimum Alveolar Concentration →

Sponsor

Tanta University

Who can join

Adults 30 to 65, any sex, with End-tidal Sevoflurane or End-tidal Carbon Dioxide. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

he assessment of adequate levels of anaesthesia traditionally relies not only on a patient's movement but also on the hemodynamic response (or both) to a surgical stimulus

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05778968 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 30 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05778968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing